CA2366719A1 - Solubilisation d'acides gras polyinsatures et de leur derives par formation de complexes d'inclusion avec la y-cyclodextrine et leur utilisation dans des compositions pharmaceutiques cosmetiques ou alimentaires - Google Patents

Solubilisation d'acides gras polyinsatures et de leur derives par formation de complexes d'inclusion avec la y-cyclodextrine et leur utilisation dans des compositions pharmaceutiques cosmetiques ou alimentaires Download PDF

Info

Publication number
CA2366719A1
CA2366719A1 CA002366719A CA2366719A CA2366719A1 CA 2366719 A1 CA2366719 A1 CA 2366719A1 CA 002366719 A CA002366719 A CA 002366719A CA 2366719 A CA2366719 A CA 2366719A CA 2366719 A1 CA2366719 A1 CA 2366719A1
Authority
CA
Canada
Prior art keywords
cyclodextrin
fatty acids
aqueous solution
complex
triglycerides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002366719A
Other languages
English (en)
French (fr)
Inventor
Florence Djedaini Pilard
Bruno Perly
Jean-Pierre Dalbiez
Quitterie Michon
Beatrice Rousseau
Pascale Barrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sea Oil
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2366719A1 publication Critical patent/CA2366719A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
CA002366719A 1999-03-09 2000-03-07 Solubilisation d'acides gras polyinsatures et de leur derives par formation de complexes d'inclusion avec la y-cyclodextrine et leur utilisation dans des compositions pharmaceutiques cosmetiques ou alimentaires Abandoned CA2366719A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9902881A FR2790758A1 (fr) 1999-03-09 1999-03-09 Solubilisation d'acides gras polyinsatures et de leurs derives par formation de complexes d'inclusion avec une cyclodextrine et leur utilisation dans des compositions pharmaceutiques, cosmetiques ou alimentaires
FR99/02881 1999-03-09
PCT/FR2000/000560 WO2000053637A1 (fr) 1999-03-09 2000-03-07 COMPLEXES D'INCLUSION D'ACIDES GRAS POLYINSATURES ET DE LEURS DERIVES AVEC LA η-CYCLODEXTRINE

Publications (1)

Publication Number Publication Date
CA2366719A1 true CA2366719A1 (fr) 2000-09-14

Family

ID=9542970

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002366719A Abandoned CA2366719A1 (fr) 1999-03-09 2000-03-07 Solubilisation d'acides gras polyinsatures et de leur derives par formation de complexes d'inclusion avec la y-cyclodextrine et leur utilisation dans des compositions pharmaceutiques cosmetiques ou alimentaires

Country Status (6)

Country Link
EP (1) EP1165620A1 (no)
JP (1) JP2002539138A (no)
CA (1) CA2366719A1 (no)
FR (1) FR2790758A1 (no)
NO (1) NO20014341D0 (no)
WO (1) WO2000053637A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10253042A1 (de) 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F
ES2209658B1 (es) * 2002-12-05 2005-10-01 Proyecto Empresarial Brudy, S.L. Utilizacion del acido docosahexaenoico como principio activo para el tratamiento de la lipodistrofia.
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
US7335386B2 (en) 2003-07-30 2008-02-26 Gerneral Mills, Inc. Method for preventing acrylamide formation in food products and food intermediates
US7105195B2 (en) 2003-07-25 2006-09-12 General Mills, Inc. Reduced trans fat product
US20040180125A1 (en) * 2003-03-11 2004-09-16 Plank David W. Cyclodextrin-containing compositions and methods
JP4870430B2 (ja) * 2003-06-20 2012-02-08 持田製薬株式会社 下肢静脈瘤予防・治療用組成物
EP2049083A2 (en) * 2006-12-27 2009-04-22 Cargill, Incorporated Stabilisation by preparing cyclodextrin inclusion complexes
FR2915901A1 (fr) * 2007-05-07 2008-11-14 In Cyclo Soc Par Actions Simpl Composition homogene et stable, riche en substances oleagineuses a base d'un produit laitier, son procede de preparation et ses utilisations.
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
GB0808479D0 (en) * 2008-05-09 2008-06-18 Uni I Oslo Topical compositions
FR3048177B1 (fr) * 2016-02-25 2020-10-30 Fabre Pierre Dermo Cosmetique Composition cosmetique biphase et son utilisation par application topique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813541A (ja) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物
JPS5941395A (ja) * 1982-09-01 1984-03-07 マルハ株式会社 魚油類の安定化方法
JPS6034156A (ja) * 1983-08-08 1985-02-21 Hayashibara Biochem Lab Inc エイコサペンタエン酸包接化合物及びこれを含有した飲食物
IT1243192B (it) * 1990-08-09 1994-05-24 Staroil Ltd Complessi di acidi grassi polinsaturi a lunga catena e di loro derivati, con ciclodestrine
JPH0725816A (ja) * 1993-07-08 1995-01-27 Yoshihisa Matsuda ポリエン酸類の包接化合物

Also Published As

Publication number Publication date
EP1165620A1 (fr) 2002-01-02
JP2002539138A (ja) 2002-11-19
FR2790758A1 (fr) 2000-09-15
NO20014341L (no) 2001-09-06
WO2000053637A1 (fr) 2000-09-14
NO20014341D0 (no) 2001-09-06

Similar Documents

Publication Publication Date Title
AU2003284633B2 (en) External composition containing polyunsaturated fatty acid or its salt or ester
EP0178442B1 (fr) Procédé d'enrichissement sélectif en acides gras polyinsaturés delta-6 d'un mélange contenant des acides gras delta-6 et delta-9, fractions enrichies obtenues et leur utilisation
US5189149A (en) Method for the production of complexes of long chain polyunsaturated fatty acids and their derivatives, with cyclodextrins, and the resulting complexes
EP0690904B1 (fr) Matieres insaponifiables d'origine vegetale et compositions cosmetiques les contenant
CA2366719A1 (fr) Solubilisation d'acides gras polyinsatures et de leur derives par formation de complexes d'inclusion avec la y-cyclodextrine et leur utilisation dans des compositions pharmaceutiques cosmetiques ou alimentaires
FR2553662A1 (fr) Composition d'acides gras combines, pour reduire les taux de triglycerides et de cholesterol du sang
FR2547829A1 (fr) Compositions contenant des composes d'acides gras insatures et procede de stabilisation de tels composes
FR2626145A1 (fr) Procede d'elimination de composes steroidiques contenus dans une substance d'origine biologique
EP0374591B1 (fr) Inhibition de l'adhésion cellulaire
CA2647089A1 (fr) Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines
JPH07238293A (ja) ドコサヘキサエン酸含有卵黄油の製造方法
FR2477413A1 (fr) Compositions cosmetiques liquides et claires pour les soins de la peau
WO1979000588A1 (en) Polyunsaturated aliphatic esters and their use as flavouring and perfuming ingredients
EP1002524B1 (fr) Composition ayant une action anti-vieillissement de la peau
FR2679109A1 (fr) Nouveaux complements nutritionnels ou dietetiques anti-vieillissement a base d'acide gras poly-insature.
FR2473887A1 (fr) Nouvelle utilisation des precurseurs biochimiques des glucosamino-glycanes et compositions pharmaceutiques et cosmetiques respectives
JPS6049747A (ja) リン脂質組成物
FR2741533A1 (fr) Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
CH622515A5 (no)
FR2839887A1 (fr) Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
WO1994002484A1 (fr) Famille de substances a noyau porphinique, leur procede d'obtention a partir de cyanophycees, et leurs applications en tant que produits cosmetiques et en tant que produits therapeutiques
WO2008152226A2 (fr) Composition homogene et stable, riche en substances oleagineuses a base d'un produit laitier, son procede de preparation et ses utilisations
WO2010136449A1 (fr) Composition d'akg et son utilisation pour la fabrication d'un médicament
FR2643637A1 (fr) Complexe d'ion calcium avec au moins un acide gras insature, agent biomediateur comprenant un tel complexe, composition pharmaceutique l'incorporant et extraits de plantes ou d'organes d'animaux en contenant
EP1685120A1 (fr) Preparations colorantes hydrosolubles jaunes derivees des dihydrochalcones

Legal Events

Date Code Title Description
FZDE Dead